Biotech

All Articles

Otsuka pays out $800M for Jnana and also its own clinical-stage PKU medicine

.Otsuka Drug has actually gotten Boston-based Jnana Therapeutics for $800 million so the Oriental bi...

FibroGen gives up 75% of US workers as possession flunks 2 additional tests

.FibroGen is radically reorganizing its own company, laying off 75% of its own USA team and stopping...

Tracon relax full weeks after injectable PD-L1 inhibitor stop working

.Tracon Pharmaceuticals has determined to wane operations full weeks after an injectable immune syst...

Ideaya bags choice on Biocytogen bispecific ADC in $400M offer

.Ideaya Biosciences is wagering $400 million in biobucks that a bispecific antibody-drug conjugate (...

Takeda takes $140M loss on fallen short epilepsy medication, touts FDA run

.Our company already know that Takeda is wishing to find a path to the FDA for epilepsy medicine sot...

VBI Vaccinations declare insolvency, seeks asset purchase

.Immunology biotech VBI Vaccinations is actually veering alarmingly near the climax, with programs t...

Celldex anti-cKIT antibody lower colonies in yet another stage 2 study

.It is actually challenging to muscle mass in on a room as very competitive as immunology, yet Celld...

Boehringer provides to $1.3 B for gate inhibitor biotech

.Boehringer Ingelheim is offering up to $1.3 billion for Nerio Therapeutics and also a preclinical i...

Ventyx's last hope for inflammatory med sides in Crohn's failing

.Ventyx Biosciences' Crohn's disease medicine did certainly not aid clients accomplish remission in ...

Cognition's period 2 beam records stain Alzheimer's possibility

.Knowledge Therapies' stage 2 luster test has taken some of the luster off the Alzheimer's condition...